Initial presentation of early rheumatoid arthritis
PLOS ONE · 06.07.2023 · 18 (7) · e0287707
DOI: 10.1371/journal.pone.0287707 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 06.07.2023. Verfasst von Lauri Weman und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Eastern Finland and Jyväskylä Central Hospital, Jyväskylä, Finland. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen, The Finnish Psoriasis Association, The Finnish Society for Rheumatology.
Abstract (Originalsprache)
Objectives
To study the joint distribution and clinical picture of rheumatoid arthritis (RA) at the initial presentation in seropositive (anti-citrullinated protein antibody (ACPA) and/or rheumatoid factor (RF) positive) and negative patients and the effect of duration of symptoms on the clinical picture.
Methods
Data of patients who received reimbursement for DMARDs for newly diagnosed RA in 1/2019 to 9/2021 were extracted from the national databases. Joint counts, presence of symmetrical swelling, other disease activity measures, and patient reported outcomes (PROs) were compared in seropositive and negative patients. Regression analyses were applied to compare clinical variables in patients with duration of symptoms of 6 months, adjusted for age, sex, and seropositivity.
Results
Data of 1816 ACPA and RF-tested patients were included. Symmetrical swelling was present in 75% of patients. Seronegative versus positive patients had higher value for all disease activity measures and PROs including median swollen joint count (SJC46 10 versus 5) and DAS28 (4.7 versus 3.7), (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Eastern Finland and Jyväskylä Central Hospital, Jyväskylä, Finland.
- Finnish Institute for Health and Welfare (THL), Data and Analytics, Helsinki, Finland.
- Department of Internal Medicine, University of Turku and Turku University Hospital, Turku, Finland.
- Division of Rheumatology, Kuopio University Hospital, Kuopio, Finland.
- Department of Children and Adolescents, Kanta-Häme Central Hospital, Hämeenlinna, Finland.
- Department of Children and Adolescents, Research Unit of Clinical Medicine, University of Oulu, Oulu University Hospital and Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
ORCID-Profile: Lauri Weman, Henri Salo, Paula Vähäsalo
Förderung
- Amgen
- The Finnish Psoriasis Association
- The Finnish Society for Rheumatology
- the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding
Zitieren
APA
Weman, L., Salo, H., Kuusalo, L., Huhtakangas, J., Kärki, J., Vähäsalo, P., Backström, M., & Sokka-Isler, T. (2023). Initial presentation of early rheumatoid arthritis. PLOS ONE, 18(7), e0287707. https://doi.org/10.1371/journal.pone.0287707
Vancouver
Weman L, Salo H, Kuusalo L, Huhtakangas J, Kärki J, Vähäsalo P, et al. Initial presentation of early rheumatoid arthritis. PLOS ONE. 2023;18(7):e0287707. doi:10.1371/journal.pone.0287707
BibTeX
@article{Weman2023,
author = {Weman, Lauri and Salo, Henri and Kuusalo, Laura and Huhtakangas, Johanna and Kärki, Johanna and Vähäsalo, Paula and Backström, Maria and Sokka-Isler, Tuulikki},
title = {Initial presentation of early rheumatoid arthritis},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {7},
pages = {e0287707},
doi = {10.1371/journal.pone.0287707}
}
EUVIMED